Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide Combined with CDOP vs CDOP in De Novo PTCL
NCT03023358Phase 3Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Feb 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tucidinostat in peripheral T-cell lymphoma (PTCL), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT03023358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03023358.